Cargando…
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation. Multi-drug therapy which consists of dapsone, rifampicin and clofazimine has been effective to combat this disease. In Indonesia, especially in Papua Island, leprosy is still a proble...
Autores principales: | Krismawati, Hana, Irwanto, Astrid, Pongtiku, Arry, Irwan, Ishak Darryl, Maladan, Yustinus, Sitanggang, Yuli Arisanti, Wahyuni, Tri, Tanjung, Ratna, Sun, Yonghu, Liu, Hong, Zhang, Furen, Oktavian, Antonius, Liu, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592909/ https://www.ncbi.nlm.nih.gov/pubmed/33064728 http://dx.doi.org/10.1371/journal.pntd.0008746 |
Ejemplares similares
-
Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol
por: Krismawati, Hana, et al.
Publicado: (2022) -
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia
por: Maladan, Yustinus, et al.
Publicado: (2021) -
A new Mycobacterium leprae dihydropteroate synthase variant (V39I) from Papua, Indonesia
por: Maladan, Yustinus, et al.
Publicado: (2019) -
Dapsone hypersensitivity syndrome
por: Zhao, Qing, et al.
Publicado: (2023) -
Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01
por: Zhao, Qing, et al.
Publicado: (2019)